NVAX Financials
Novavax Inc - Financial statements & key metrics
Stock Price
$10.07
Market Cap
$1.09B
P/E Ratio
3.9
EPS
$2.25
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$682.16M
Gross Profit
-
Operating Income
-
Net Income
$-187.50M
EPS (Diluted)
$-1.23
Balance Sheet Highlights
Total Assets
$1.56B
Total Liabilities
$2.18B
Shareholders Equity
-
Cash & Equivalents
$530.23M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-87.26M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-112.7%
Net Margin
32.1%
ROE
-898.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is NVAX revenue?
NVAX's most recent quarterly revenue was $682.16M. Annual revenue can be calculated by summing the four most recent quarters.
Is NVAX profitable?
NVAX reported a loss of $187.50M in the most recent quarter. The net profit margin is 32.1%.
What is NVAX market cap?
NVAX has a market capitalization of $1.09B, making it a small-cap stock.
Does NVAX have debt?
View NVAX's balance sheet for debt information.
What is NVAX cash flow?
Cash flow data is available in the full financial statements.